An additional 8 patients (50%) had SD, 3 patients (19%) were rated as PD, and 1 patient transformed to gastric diffuse large B‐cell lymphoma and was consequently treated with R‐CHOP, resulting in CR. The gene discussed is DDIT3; the disease is diffuse large B-cell lymphoma.